Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome.
Harner
K C
KC
Jackson
L W
LW
Drabick
J J
JJ
D017153:Antibodies, Anticardiolipin / Q000032:analysis*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy*; D008875:Middle Aged; D000069283:Rituximab; D012859:Sjogren's Syndrome / Q000150:complications*; D016896:Treatment Outcome
D017153:Antibodies, Anticardiolipin; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab